340 related articles for article (PubMed ID: 17666364)
1. Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival.
Stilgenbauer S; Sander S; Bullinger L; Benner A; Leupolt E; Winkler D; Kröber A; Kienle D; Lichter P; Döhner H
Haematologica; 2007 Sep; 92(9):1242-5. PubMed ID: 17666364
[TBL] [Abstract][Full Text] [Related]
2. High-risk clonal evolution in chronic B-lymphocytic leukemia: single-center interphase fluorescence in situ hybridization study and review of the literature.
Janssens A; Van Roy N; Poppe B; Noens L; Philippé J; Speleman F; Offner F
Eur J Haematol; 2012 Jul; 89(1):72-80. PubMed ID: 22509718
[TBL] [Abstract][Full Text] [Related]
3. Genetics of chronic lymphocytic leukemia: genomic aberrations and V(H) gene mutation status in pathogenesis and clinical course.
Stilgenbauer S; Bullinger L; Lichter P; Döhner H;
Leukemia; 2002 Jun; 16(6):993-1007. PubMed ID: 12040431
[TBL] [Abstract][Full Text] [Related]
4. Clonal evolution in chronic lymphocytic leukemia: analysis of correlations with IGHV mutational status, NOTCH1 mutations and clinical significance.
López C; Delgado J; Costa D; Villamor N; Navarro A; Cazorla M; Gómez C; Arias A; Muñoz C; Cabezas S; Baumann T; Rozman M; Aymerich M; Colomer D; Pereira A; Cobo F; López-Guillermo A; Campo E; Carrió A
Genes Chromosomes Cancer; 2013 Oct; 52(10):920-7. PubMed ID: 23893575
[TBL] [Abstract][Full Text] [Related]
5. Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome.
Tobin G; Thunberg U; Laurell A; Karlsson K; Aleskog A; Willander K; Söderberg O; Merup M; Vilpo J; Hultdin M; Sundström C; Roos G; Rosenquist R
Haematologica; 2005 Apr; 90(4):465-9. PubMed ID: 15820941
[TBL] [Abstract][Full Text] [Related]
6. IgVH gene mutation status and genomic imbalances in chronic lymphocytic leukaemia with increased prolymphocytes (CLL/PL).
Balogh Z; Reiniger L; Deák L; Bödör C; Csomor J; Szepesi A; Gagyi E; Kopper L; Matolcsy A
Hematol Oncol; 2007 Jun; 25(2):90-5. PubMed ID: 17410523
[TBL] [Abstract][Full Text] [Related]
7. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia.
Kröber A; Seiler T; Benner A; Bullinger L; Brückle E; Lichter P; Döhner H; Stilgenbauer S
Blood; 2002 Aug; 100(4):1410-6. PubMed ID: 12149225
[TBL] [Abstract][Full Text] [Related]
8. Role of cytogenetic abnormalities detected by fluorescence
Shetty D; Jain H; Rohil Y; Khattry N; Sengar M; Bagal B; Jain H; Gokarn A; Punatar S; Avinash Bonda VN; Subramanian PG
Indian J Med Res; 2021 Apr; 153(4):475-483. PubMed ID: 34380794
[TBL] [Abstract][Full Text] [Related]
9. VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemia.
Aleskog A; Tobin G; Laurell A; Thunberg U; Lindhagen E; Roos G; Nilsson K; Nygren P; Sundström C; Höglund M; Larsson R; Rosenquist R
Eur J Haematol; 2004 Dec; 73(6):407-11. PubMed ID: 15522062
[TBL] [Abstract][Full Text] [Related]
10. Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients.
Cavazzini F; Rizzotto L; Sofritti O; Daghia G; Cibien F; Martinelli S; Ciccone M; Saccenti E; Dabusti M; Elkareem AA; Bardi A; Tammiso E; Cuneo A; Rigolin GM
Leuk Lymphoma; 2012 Jan; 53(1):83-8. PubMed ID: 21767243
[TBL] [Abstract][Full Text] [Related]
11. Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH status.
Kim SZ; Chow KU; Kukoc-Zivojnov N; Boehrer S; Brieger A; Steimle-Grauer SA; Harder L; Hoelzer D; Mitrou PS; Weidmann E
Leuk Lymphoma; 2004 Oct; 45(10):2037-45. PubMed ID: 15370248
[TBL] [Abstract][Full Text] [Related]
12. Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia.
Kröber A; Bloehdorn J; Hafner S; Bühler A; Seiler T; Kienle D; Winkler D; Bangerter M; Schlenk RF; Benner A; Lichter P; Döhner H; Stilgenbauer S
J Clin Oncol; 2006 Feb; 24(6):969-75. PubMed ID: 16418492
[TBL] [Abstract][Full Text] [Related]
13. Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL.
Kern W; Bacher U; Haferlach C; Dicker F; Alpermann T; Schnittger S; Haferlach T
Br J Haematol; 2012 Apr; 157(1):86-96. PubMed ID: 22224978
[TBL] [Abstract][Full Text] [Related]
14. Genetic features of B-cell chronic lymphocytic leukemia.
Stilgenbauer S; Lichter P; Döhner H
Rev Clin Exp Hematol; 2000 Mar; 4(1):48-72. PubMed ID: 11486330
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-).
Caballero D; García-Marco JA; Martino R; Mateos V; Ribera JM; Sarrá J; León A; Sanz G; de la Serna J; Cabrera R; González M; Sierra J; San Miguel J
Clin Cancer Res; 2005 Nov; 11(21):7757-63. PubMed ID: 16278397
[TBL] [Abstract][Full Text] [Related]
16. Examination of clonal evolution in chronic lymphocytic leukemia.
Koczkodaj D; Popek-Marciniec S; Zmorzyński S; Wąsik-Szczepanek E; Filip AA
Med Oncol; 2019 Aug; 36(9):79. PubMed ID: 31375939
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax.
Tausch E; Schneider C; Robrecht S; Zhang C; Dolnik A; Bloehdorn J; Bahlo J; Al-Sawaf O; Ritgen M; Fink AM; Eichhorst B; Kreuzer KA; Tandon M; Humphrey K; Jiang Y; Schary W; Bullinger L; Mertens D; Lurà MP; Kneba M; Döhner H; Fischer K; Hallek M; Stilgenbauer S
Blood; 2020 Jun; 135(26):2402-2412. PubMed ID: 32206772
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997.
Grever MR; Lucas DM; Dewald GW; Neuberg DS; Reed JC; Kitada S; Flinn IW; Tallman MS; Appelbaum FR; Larson RA; Paietta E; Jelinek DF; Gribben JG; Byrd JC
J Clin Oncol; 2007 Mar; 25(7):799-804. PubMed ID: 17283363
[TBL] [Abstract][Full Text] [Related]
19. [Fluorescent in situ hybridization with a panel of probes detects molecular cytogenetic abnormalities in patients with chronic lymphocytic leukemia].
Xu W; Li JY; Li L; Yu H; Shen QD; Fan L; Qiao C; Hong M; Qian SX; Qiu HX
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2537-40. PubMed ID: 19080644
[TBL] [Abstract][Full Text] [Related]
20. Interphase fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia.
Xu W; Li JY; Pan JL; Qiu HR; Shen YF; Li L; Wu YF; Xue YQ
Int J Hematol; 2007 Jun; 85(5):430-6. PubMed ID: 17562621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
